Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

Ads

You May Also Like

Optinose Expands Leadership Team with Key Hires

YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused ...

Catalyst Pharmaceuticals Expands Commercial Leadership Team

Augments Medical Affairs Team with 3 Additional Medical Science LiaisonsCORAL GABLES, Fla., Aug. 06, ...